Toxicology – Black Widow Spider

Core concept

Black widow spider envenomation causes a painful neurotoxic syndrome known as latrodectism.

The characteristic syndrome is:

Painful bite → spreading muscle pain and spasm → autonomic hyperactivity

Typical systemic findings include:

• Severe muscle cramping
• Abdominal or back pain
• Diaphoresis
• Hypertension
• Tachycardia
• Nausea and vomiting

Most patients recover completely, and death is very rare. A large U.S. poison-center review cited by Poison Control found no deaths among more than 15,000 reported exposures.

Important Species

Clinically important Latrodectus spiders include:

• Latrodectus mactans – black widow
• Latrodectus hesperus – western black widow
• Other Latrodectus species in North America and elsewhere
• Latrodectus hasselti – Australian redback spider

The older source incorrectly groups some brown and red widow species under L. hesperus; these are distinct taxa.

Toxic Dose

A single envenomating bite can produce clinically important toxicity.

Severity is influenced by:

• Amount of venom injected
• Patient size
• Age
• Underlying cardiovascular or pulmonary disease

Children and older adults may experience more severe systemic effects.

Pathophysiology

The major venom component is α-latrotoxin.

It causes massive presynaptic neurotransmitter release, including:

• Acetylcholine
• Norepinephrine
• Other neurotransmitters

The result is:

Excess neurotransmitter release → painful skeletal muscle contraction + autonomic hyperactivity

This produces the characteristic combination of:

• Muscle spasm
• Severe pain
• Hypertension
• Tachycardia
• Sweating

Clinical Features

Local Findings

The bite may initially cause:

• Immediate or rapidly developing pain
• Mild erythema
• Small puncture marks
• Local swelling
• Local diaphoresis

The local wound is often relatively unimpressive compared with the severity of systemic pain.

Latrodectism

Pain typically spreads from the bite site to larger muscle groups over approximately 30 minutes to several hours.

For example:

Arm bite → shoulder/chest pain

or

Leg bite → thigh/buttock/abdominal pain

This migration of severe muscle pain and spasm is highly suggestive.

Musculoskeletal

Characteristic findings include:

• Severe muscle cramps
• Painful spasms
• Abdominal-wall rigidity
• Back pain
• Chest-wall pain

The abdomen may become boardlike, creating a presentation that resembles an acute surgical abdomen.

Rarely:

• Rhabdomyolysis may occur

Autonomic Findings

Common manifestations include:

• Diaphoresis
• Hypertension
• Tachycardia
• Restlessness
• Anxiety

Sweating may sometimes be strikingly localized near the bite.

Gastrointestinal

Common symptoms include:

• Nausea
• Vomiting
• Abdominal pain
• Abdominal cramping

Abdominal rigidity may mimic:

• Appendicitis
• Peritonitis
• Other acute abdominal emergencies

Cardiovascular

Possible effects include:

• Hypertension
• Tachycardia

Rare severe complications include:

• Dysrhythmias
• Myocardial injury
• Myocarditis
• Ischemia-like chest pain

An ECG is appropriate when significant hypertension or chest pain occurs.

Pulmonary

Possible manifestations include:

• Tachypnea
• Dyspnea
• Respiratory distress

True respiratory failure is uncommon but has been reported.

Neurologic

Possible findings include:

• Headache
• Anxiety
• Restlessness
• Paresthesias
• Weakness
• Hyperreflexia

Children may present less specifically with:

• Irritability
• Agitation
• Drowsiness
• Abdominal pain

Diagnosis

Diagnosis is primarily clinical.

Think of:

Compatible exposure + severe spreading muscle pain/spasm + diaphoresis/autonomic findings

The spider does not need to be captured or identified for diagnosis.

Differential Diagnosis

Important mimics include:

• Acute surgical abdomen
• Myocardial ischemia
• Renal colic
• Biliary disease
• Pancreatitis
• Sickle-cell crisis
• Tetanus
• Other causes of severe muscle cramping

Upper-extremity bites may produce chest pain that resembles myocardial ischemia.

Laboratory Testing

No specific laboratory test confirms routine black widow envenomation.

Mild cases

Laboratory testing is often unnecessary.

Significant systemic toxicity

Consider:

• CBC
• Electrolytes
• Renal function
• Glucose
• Creatine kinase
• Urinalysis

Possible nonspecific abnormalities include leukocytosis and occasionally elevated CK or evidence of muscle injury.

Additional Testing

Chest pain or significant hypertension

• ECG
• Cardiac assessment as clinically indicated

Prolonged severe muscle spasm

• CK
• Renal function
• Urinalysis

Respiratory distress

• Pulse oximetry
• Blood gas when indicated

Severe abdominal presentation

Appropriate evaluation may be necessary to exclude a genuine surgical abdomen.

Treatment

1. Initial Care

Treatment begins with:

• Airway and breathing assessment
• Vital-sign monitoring
• Local wound cleaning
• Appropriate tetanus prophylaxis
• Analgesia

Routine incision, suction, or other invasive local treatment is not indicated.

2. Mild Envenomation

For pain confined largely to the bite region:

• Oral analgesics
• Local wound care
• Observation for progression

Most mild cases are self-limited.

3. Moderate to Severe Envenomation

For severe spreading pain and muscle spasm:

Opioid analgesia

Opioids are effective for severe pain and can be titrated to clinical response.

Benzodiazepines

Benzodiazepines may be used for:

• Severe muscle spasm
• Agitation associated with systemic envenomation

Because combining opioids and benzodiazepines increases the risk of respiratory depression, patients receiving both require appropriate monitoring.

Calcium Gluconate

Older toxicology texts frequently recommended IV calcium gluconate.

Current evidence indicates:

Calcium gluconate is not reliably effective for latrodectism and is no longer routinely recommended.

Methocarbamol

Similarly:

Methocarbamol is not considered reliably effective and is not routinely recommended.

Antivenom

Role

Black widow antivenom can produce rapid improvement in:

• Severe pain
• Muscle spasm
• Systemic symptoms

In the United States, Antivenin (Latrodectus mactans) (Equine) remains an FDA-licensed biologic.

However, availability may vary between hospitals, and Poison Control notes that it is used relatively rarely.

When to Consider Antivenom

Antivenom is generally reserved for significant systemic envenomation, especially when there is:

• Severe persistent pain despite adequate analgesia
• Severe muscle spasm
• Significant autonomic toxicity
• Respiratory compromise
• Serious cardiovascular effects

It may also be considered when severe symptoms cannot be adequately controlled with supportive therapy.

U.S. Antivenom Dose

The current U.S. product label specifies:

Adults and children: entire contents of one reconstituted single-dose vial

For severe cases, IV administration is preferred:

One vial diluted in 10–50 mL saline and administered IV over approximately 15 minutes.

One vial is usually sufficient, although a second dose may occasionally be necessary.

Antivenom administration should follow the specific product labeling and local poison-center/toxicology guidance.

Antivenom Adverse Effects

Because the U.S. product is equine-derived, adverse reactions may include:

• Immediate hypersensitivity
• Anaphylaxis
• Delayed serum sickness

The manufacturer recommends monitoring for serum sickness in the following days after treatment.

A negative hypersensitivity skin test does not guarantee that an allergic reaction will not occur.

Therefore, antivenom should be given where:

• Airway management is immediately available
• Epinephrine and anaphylaxis treatment are available
• The patient can be appropriately monitored

Pregnancy

Black widow envenomation during pregnancy raises concern because severe pain, muscle spasm, and autonomic effects could potentially affect uterine activity.

However, reported pregnancy outcomes are generally favorable.

Management should prioritize:

• Maternal stabilization
• Adequate analgesia
• Treatment of significant systemic toxicity
• Obstetric assessment when clinically appropriate

Symptomatic pregnant patients may warrant closer observation.

Monitoring

Patients with significant systemic symptoms should have:

• Repeated vital signs
• Respiratory monitoring
• Cardiac monitoring when cardiovascular toxicity is present
• Serial pain and neurologic assessment

Patients receiving:

• Opioids plus benzodiazepines
• Antivenom

require particularly close monitoring.

Admission

Hospital admission should be considered for:

• Persistent severe pain despite treatment
• Significant hypertension
• Cardiovascular complications
• Respiratory distress
• Severe vomiting/dehydration
• Significant systemic toxicity
• Need for repeated parenteral analgesia
• Complications such as rhabdomyolysis

ICU care may be required for severe cardiopulmonary toxicity.

Disposition

A fixed observation period is less important than the clinical course.

Patients may be discharged when:

• Pain is adequately controlled
• Muscle spasm is improving
• Vital signs are stable
• No progressive systemic toxicity is present
• Oral intake and mobility are adequate

Mild cases may improve rapidly; significant latrodectism can persist considerably longer.

Expected Course and Prognosis

Symptoms generally peak within the first several hours.

Most patients improve substantially within:

24–48 hours

although:

• Muscle soreness
• Fatigue
• Weakness
• Residual pain

may persist for several days or occasionally longer.

Permanent sequelae are unusual.

Important Pitfalls

1. Mistaking latrodectism for an acute abdomen

Severe abdominal muscle spasm may create striking rigidity.

A careful history and examination are essential.

2. Missing cardiac disease

Chest pain after an upper-extremity bite may mimic ischemia, but genuine myocardial disease must still be excluded when clinically appropriate.

3. Using calcium gluconate routinely

Older sources commonly recommended calcium.

Current evidence does not support routine calcium gluconate for pain or spasm.

4. Undertreating pain

Severe latrodectism can be extraordinarily painful.

Adequate opioid analgesia and appropriate treatment of muscle spasm are central to supportive care.

5. Combining opioids and benzodiazepines without monitoring

The combination can cause respiratory depression.

6. Forgetting antivenom hypersensitivity

Equine-derived antivenom can cause:

• Anaphylaxis
• Serum sickness

7. Assuming the bite site must look dramatic

The local wound may be subtle despite severe systemic toxicity.

High-Yield Toxicology Pearls

Black widow bite = painful muscle spasm + autonomic hyperactivity

Think:

Bite → spreading pain → abdominal/back muscle spasm + sweating + hypertension

Key points:

• Syndrome: latrodectism
• Major toxin: α-latrotoxin
• Mechanism: massive presynaptic neurotransmitter release
• Severe muscle pain and cramping may begin within minutes to hours
• Abdominal rigidity may mimic an acute surgical abdomen
• Diaphoresis, hypertension, and tachycardia are characteristic
• Routine laboratory testing is unnecessary in mild cases
• Main treatment: analgesia + supportive care
• Opioids are used for severe pain
• Benzodiazepines may help significant muscle spasm
• Calcium gluconate is no longer routinely recommended
• Methocarbamol is not reliably effective
• Antivenom can rapidly improve severe or refractory symptoms
• U.S. antivenom is equine-derived and carries anaphylaxis/serum-sickness risk
• U.S. labeled dose: one vial, with IV administration preferred in severe cases
• Death is very rare
• Most patients recover completely